U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Bumetanide Injection
Status: Currently in Shortage
»Date first posted: 12/13/2017
»Therapeutic Categories: Cardiovascular

Expand all

Athenex Pharmaceutical Division, LLC (Athenex) (Reverified 09/28/2022)

Company Contact Information:
855-273-0154

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1mg/4mL vial (NDC 70860-405-04) Available
2.5mg/10mL vial (NDC 70860-406-10) Available

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 08/26/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.25 mg/mL, 4 mL vial (NDC 0641-6008-10) Inventory is currently available Demand increase for the drug
0.25 mg/mL, 10 mL vial (NDC 0641-6007-10) Inventory is currently available Demand increase for the drug

Hospira, Inc. (Revised 09/12/2022)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/4 mL (0.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1412-04) Next Delivery and Estimated Recovery: September 2022 Demand increase for the drug
2.5 mg/10 mL (0.25 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1412-10) Next Delivery and Estimated Recovery: February 2025 Demand increase for the drug
Back to Top